S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
Log in

NYSE:METMetlife Stock Price, Forecast & News

$35.46
+1.99 (+5.95 %)
(As of 04/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$34.41
Now: $35.46
$36.36
50-Day Range
$23.53
MA: $36.29
$52.28
52-Week Range
$22.85
Now: $35.46
$53.28
Volume10.68 million shs
Average Volume7.86 million shs
Market Capitalization$32.48 billion
P/E Ratio5.86
Dividend Yield5.26%
Beta1.3
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. The company serves individuals, corporations and their employees, and other institutions and their members through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and sponsoring organizations and affinity groups, as well as through career and independent agencies, bancassurance, direct marketing and e-commerce, brokers, and other third-party distribution channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
Read More
Metlife logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.9Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.76 out of 5 stars


Industry, Sector and Symbol

Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
CUSIP59156R10
Phone212-578-9500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$69.62 billion
Cash Flow$6.59 per share
Book Value$72.18 per share

Profitability

Net Income$5.90 billion

Miscellaneous

Employees49,000
Market Cap$32.48 billion
Next Earnings Date5/6/2020 (Confirmed)
OptionableOptionable

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.


Metlife (NYSE:MET) Frequently Asked Questions

How has Metlife's stock been impacted by COVID-19 (Coronavirus)?

Metlife's stock was trading at $33.30 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MET stock has increased by 6.5% and is now trading at $35.46. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Metlife?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 5 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Metlife.

When is Metlife's next earnings date?

Metlife is scheduled to release its next quarterly earnings announcement on Wednesday, May 6th 2020. View our earnings forecast for Metlife.

How can I listen to Metlife's earnings call?

Metlife will be holding an earnings conference call on Wednesday, May 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) issued its earnings results on Wednesday, February, 5th. The financial services provider reported $1.98 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.40 by $0.58. The financial services provider had revenue of $18.15 billion for the quarter, compared to analysts' expectations of $16.82 billion. Metlife had a return on equity of 9.14% and a net margin of 8.39%. The company's revenue for the quarter was up 17.9% on a year-over-year basis. During the same quarter last year, the business earned $1.35 EPS. View Metlife's earnings history.

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife declared a quarterly dividend on Tuesday, January 7th. Stockholders of record on Tuesday, February 4th will be given a dividend of $0.44 per share on Friday, March 13th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 4.96%. The ex-dividend date is Monday, February 3rd. View Metlife's dividend history.

How will Metlife's stock buyback program work?

Metlife declared that its Board of Directors has authorized a share repurchase program on Thursday, November 1st 2018, which allows the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to buy up to 4.6% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's management believes its shares are undervalued.

What price target have analysts set for MET?

10 analysts have issued 12-month price targets for Metlife's shares. Their forecasts range from $32.00 to $60.00. On average, they anticipate Metlife's stock price to reach $44.22 in the next twelve months. This suggests a possible upside of 24.7% from the stock's current price. View analysts' price targets for Metlife.

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:
  • 1. According to Zacks Investment Research, "MetLife’s shares have outperformed its industry, year to date. It has been performing well led by prudent underwriting and expense management. Its efforts to streamline business and focus on core operations are impressive. Acquisitions made by the company will diversify its business and aid inorganic growth. Its disciplined capital deployment is expected to drive long-term growth and create wealth for shareholders. However, its exposure to catastrophe loss remains a concern. Investment in efficiency programs will likely put pressure on margins. Also, the company's net investment income might continue to decline in 2019 due to lower interest rates, which will likely pressurize investment yields." (12/9/2019)
  • 2. Wells Fargo & Co analysts commented, "We do not expect much movement in the shares after our meetings. Our EPS estimates and price target are unchanged. We continue to have an Outperform rating on the shares." (6/5/2019)

Has Metlife been receiving favorable news coverage?

Headlines about MET stock have trended very negative recently, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Metlife earned a news impact score of -3.3 on InfoTrie's scale. They also assigned news coverage about the financial services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutMetlife.

Are investors shorting Metlife?

Metlife saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 17,836,800 shares, an increase of 23.2% from the February 27th total of 14,480,000 shares. Based on an average daily trading volume, of 6,410,000 shares, the short-interest ratio is currently 2.8 days. Currently, 2.3% of the shares of the stock are sold short. View Metlife's Current Options Chain.

Who are some of Metlife's key competitors?

What other stocks do shareholders of Metlife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Metlife investors own include AT&T (T), General Electric (GE), Verizon Communications (VZ), Pfizer (PFE), Walt Disney (DIS), IBM (IBM), Bank of America (bac), Exxon Mobil (XOM), Johnson & Johnson (JNJ) and Intel (INTC).

Who are Metlife's key executives?

Metlife's management team includes the following people:
  • Mr. Michel A. Khalaf, CEO, Pres & Director (Age 55)
  • Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 45)
  • Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)
  • Ms. Tamara L. Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 47)
  • Mr. John Arthur Hall, Sr. VP & Head of Investor Relations

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Who are Metlife's major shareholders?

Metlife's stock is owned by many different institutional and retail investors. Top institutional shareholders include State of Alaska Department of Revenue (0.02%), Abner Herrman & Brock LLC (0.02%), M&G Investment Management Ltd. (0.02%), Cullinan Associates Inc. (0.01%), IFM Investors Pty Ltd (0.01%) and Verity & Verity LLC (0.01%). Company insiders that own Metlife stock include Carlos M Gutierrez, Gerald L Hassell, John D Mccallion, Steven A Kandarian and Steven J Goulart. View institutional ownership trends for Metlife.

Which institutional investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Verity & Verity LLC, Abner Herrman & Brock LLC, M&G Investment Management Ltd., IFM Investors Pty Ltd, and Burns J W & Co. Inc. NY. View insider buying and selling activity for Metlife.

Which institutional investors are buying Metlife stock?

MET stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Cullinan Associates Inc., IBM Retirement Fund, Wiley BROS. Aintree Capital LLC, CHICAGO TRUST Co NA, 180 Wealth Advisors LLC, Pinnacle Bank, and KG&L Capital Management LLC. Company insiders that have bought Metlife stock in the last two years include Carlos M Gutierrez, and Gerald L Hassell. View insider buying and selling activity for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $35.46.

How big of a company is Metlife?

Metlife has a market capitalization of $32.48 billion and generates $69.62 billion in revenue each year. The financial services provider earns $5.90 billion in net income (profit) each year or $6.11 on an earnings per share basis. Metlife employs 49,000 workers across the globe. View additional information about Metlife.

What is Metlife's official website?

The official website for Metlife is http://www.metlife.com/.

How can I contact Metlife?

Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

This page was last updated on 4/9/2020 by MarketBeat.com Staff

Featured Article: What is a resistance level?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel